A Phase 3 Randomized, Double-blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 vaginal ring) in Women with Moderate to Severe Primary Dysmenorrhea.
Sponsor: |
Merck |
Enrolling: |
Female Patients Only |
IRB Number: |
AAAQ6277 |
U.S. Govt. ID: |
NCT02668822 |
Contact: |
Claudia Roca: 212-342-2986 / cr479@cumc.columbia.edu |
You may be eligible if you are younger than 51 years old, have regular monthly periods with moderate to severe cramping, and are willing to try a NEW hormonal vaginal ring. The ring contains estrogen and progestin which are hormones found in some types of birth control pills, patches and rings.Participation in the study will consist of 6 study visits and 2 telephone contacts over 8 months. The visits will vary but mostly consist of physical check-ups, urine pregnancy testing, blood pressure checks, with occasional gynecological exams and blood draws. You will also be required to record information every day in a small electronic diary. Adolescents and women who are not sexually active may be eligible to participate.Compensation: up to $1000 for time and travel
This study is closed
Investigator
Anne Davis, MD
Do you have regular monthly periods with moderate to severe cramping? |
Yes |
No |